PlainRecalls

Sciegen Pharmaceuticals Inc

Compiled from official public sources by the publisher.

7 recalls on record · Latest: Mar 8, 2023

Subscribe to new Sciegen Pharmaceuticals Inc recalls (RSS)

Agency notice ledger

Federal filing book Sciegen Pharmaceuticals Inc LIGHT-BOOK · SINGLE-AGENCY

#2,019 of 14,151 · 7 notices · 0.007% archive

  • BOOK 7 notices
  • RANK #2,019 of 14,151
  • SHARE 0.007% archive
  • AGENCY FDA Drug (7)
  • CAT children
  • CATS 1 category
  • LATEST Mar 8, 2023
  • PHOTO A I Foods Corporation

Nearest notice-volume peer: A I Foods Corporation (0 notice gap)

Sciegen Pharmaceuticals Inc accounts for about 0.007% of the 104,423-notice archive on 7 distinct filings — a mid share signal beside absolute volume. FDA · CPSC · USDA FSIS · NHTSA notice stamps for this firm. Read with this firm → · Dominant category → · Similar-volume firm →

How Sciegen Pharmaceuticals Inc compares to 14,151 recalling firms

Sciegen Pharmaceuticals Inc ranks 2,019th of 14,151 tracked firms by distinct recall-event count. Archive size reflects filing volume, not inherent product danger.

Sciegen Pharmaceuticals Inc vs all firms by recall-notice count

Where this firm's archive sits among every tracked recalling manufacturer

7 2019th of 14151 higher than 12,091 of 14,151 firms

Firms, banded by distinct federal recall-event inventory

Each bar is a band; taller bars hold more firms. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source FDA · CPSC · USDA FSIS · NHTSA federal recall filings · 2026-09-13

Sciegen Pharmaceuticals Inc in the notice-volume neighbourhood

Distinct federal recall events among this firm and nearest nationwide peers

notices

What this shows Sciegen Pharmaceuticals Inc holds about 0.007% of archive notices alongside 7 distinct filings.

Source FDA · CPSC · USDA FSIS · NHTSA filings aggregated by PlainRecalls As of September 2026
FDA Drug Low Mar 8, 2023

Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.
FDA Drug Moderate Nov 28, 2018

Westminister Irbesartan Tablets, USP, 75 mg (a) 30-count bottle (NDC 69367-119-01), (b) 90-count bottle (NDC 69367-119-03), Rx Only, Manufactured by ScieGen Pharmaceuticals Inc Hauppauge, NY 11755 Manufactured for Westminister Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA
FDA Drug Moderate Nov 28, 2018

GSMS Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 60429-641-30), (b) 90-count bottle (NDC 60429-641-90), Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Marketed by: GSMS Incorporated Camarillo, CA 93012 USA.
FDA Drug Moderate Nov 28, 2018

Westminister Irbesartan Tablets, USP, 150 mg, (a) 30-count bottle (NDC 69367-120-01), (b) 90-count bottle (NDC 69367-120-03), Rx Only, Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755, Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854, Made in the USA.
FDA Drug Moderate Nov 28, 2018

GSMS Irbesartan Tablets, USP, 75 mg, 30-count bottle, Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788 Marketed by: GSMS Incorporated Camarillo, CA 93012 USA, NDC 60429-640-90.
FDA Drug Moderate Nov 28, 2018

GSMS Irbesartan Tablets, USP, 300 mg,(a) 30-count bottle (NDC 60429-642-30), (b) 90-count bottle (NDC 60429-642-90), Rx Only, Manufactured by ScieGen Pharmaceuticals, Inc. Hauppauge, NY 11788, Marketed by: GSMS Incorporated Camarillo, CA 93012 USA.
FDA Drug Moderate Nov 28, 2018

Westminister Irbesartan Tablets, USP, 300mg, Rx Only,(a) 30-count bottle (NDC 69367-121-01, (b) 90-count bottle (NDC 69367-121-03), Manufactured by ScieGen Pharmaceuticals Inc. Hauppauge, NY 11755. Manufactured for Westminster Pharmaceuticals LLC Olive Branch, MS 20854 Made in the USA.

Sciegen Pharmaceuticals Inc holds a measurable archive slice

Drug and device firms outside this manufacturer and state, matched by notice volume and category footprint.

Frequently Asked Questions

How many federal recall notices name Sciegen Pharmaceuticals Inc? ▼
PlainRecalls indexes 7 distinct federal recall events naming Sciegen Pharmaceuticals Inc, aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (archive as of September 2026). That count is an issuance inventory, not a hazard score.
Where does Sciegen Pharmaceuticals Inc sit among other recalling firms? ▼
Sciegen Pharmaceuticals Inc ranks #2,019 of 14,151 by distinct recall-event count among 14,151 firms in this archive (85th percentile of firms with fewer notices). Rank tracks filing frequency, not product danger.
Which agency issues most of Sciegen Pharmaceuticals Inc's notices? ▼
FDA Drug accounts for 7 of this firm's 7 indexed notices.
What product category dominates Sciegen Pharmaceuticals Inc's filing book? ▼
Filings for Sciegen Pharmaceuticals Inc span 1 product category, led by children. Browse that category archive for peer firms and related notices.
Is a higher notice count more dangerous? ▼
No. Archive size reflects how often federal agencies publish recalls naming the firm — reporting volume, coverage, and product range all move the number. Always verify the individual notice with the issuing agency before acting on a specific product.
Sciegen Pharmaceuticals Inc: 7 federal recall notices aggregated from FDA, CPSC, USDA FSIS, and NHTSA filings (lead agency FDA Drug). Verify individual notices with FDA directly before acting on a specific recall.

Firm-level totals aggregate distinct federal recall events naming Sciegen Pharmaceuticals Inc; individual notices remain authoritative on each linked recall page.

Methodology · Corrections · FDA · CPSC · USDA FSIS · NHTSA · Archive as of September 2026